Pharma Joint Ventures In Chinese Province

25 March 1996

A total of 63 joint ventures with foreign pharmaceutical companies have been set up within China's Zhejiang province.

the drug industry is centered in the provincial capital Hangzhou, where nine foreign drug companies have invested $87.9 million since the beginning of 1995. The province plans to make the drug sector a pillar industry during the Ninth Five-Year Plan period (1996-2000).

In 1994, Merck Sharp & Dohme invested $26 million in a joint venture with a Hangzhou company to set up what the province called the world's largest drug plant; the plant can produce 100 million tablets per year. Sanofi has invested $15 million in setting up a joint venture, and Allergan also invested $29.7 million to open a branch in the provincial capital.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight